Skip to content

Clinical Study on the relief of Shoulder joint Pain by ketoprofen Cataplasms: A randomized controlled trial

Clinical Study on the relief of Shoulder joint Pain by ketoprofen Cataplasms: A randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115128
Enrollment
Unknown
Registered
2025-12-23
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder joint pain

Interventions

Experimental Group:Ketoprofen gel plaster: For external use, apply it to the affected area. One patch each time, twice a day, for two consecutive weeks
Control group:Flurbiprofen gel patch: Apply externally to the painful area, twice a day, one patch per area per time, for two consecutive weeks

Sponsors

Jiangxi Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with shoulder joint pain; 2. The patient is in a period of pain; 3. Those who have not taken other relevant treatment drugs (such as oral diclofenac sodium sustained-release tablets, loxoprofen sodium tablets, etc.) or received other forms of treatment within 4 weeks before screening; 4. Age: 30 to 70 years old (including 30 and 70 years old), gender not limited; 5. The subjects voluntarily agreed to participate in this study and signed a written informed consent form;

Exclusion criteria

Exclusion criteria: 1. Patients who have received relevant treatments in the past, or those with possible effect indicators that may affect this study; 2. Patients with severe primary diseases such as diabetes, tumors, cardiovascular and cerebrovascular diseases, blood disorders, and mental illnesses; 3. Pregnant patients; 4. Those who have a history of allergic reactions to the drugs used in this study in the past; 5. Other circumstances where the researcher deems it inappropriate to participate in this trial.

Design outcomes

Primary

MeasureTime frame
Overall effective rate;

Secondary

MeasureTime frame
VAS Score;CMS Score;Application comfort;

Countries

China

Contacts

Public ContactLiu Xiaobing

Jiangxi Provincial People's Hospital

784638078@qq.com+86 158 0251 7598

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026